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The thrombin generation test is one of the diagnostic tests currently in use as a universal method for
measuring hemostatic disorders. We envisioned that conventional monitoring of thrombin
generation could be miniaturized resulting in a time-saving, accurate, easy-to-operate, and
cost-efficient test. For the translation of the conventional thrombin generation test to microfluidic
devices, our focus was directed to parameters such as the detection limit, temperature,
protein-surface interactions i.e., hydrophilicity of microchannels, and mixing behavior. Scaling
down to microchannels e.g., capillaries resulted in volume reduction and allowed us to study the
effect of a microchannel surface either hydrophilic or hydrophobic on the thrombin activity.
Finally, the use of a micromixer enabled us to perform efficient on-chip mixing, resulting in the
successful measurement of a thrombin generation in a microfluidic device.
© 2009 American Institute of Physics. DOI: 10.1063/1.3116634
I. INTRODUCTION
Coronary heart disease, stroke and other cerebrovascular
diseases, chronic obstructive pulmonary disease, HIV/AIDS,
and lower respiratory infections are currently the primary
causes of death worldwide.1 With more than 22106 fatali-
ties annually, the demand for cheap, rapid, and reliable diag-
nostic tests for these diseases is ever increasing.2 In particu-
lar, cardiac diagnostic tests have received significant
attention as cardiovascular diseases cover nearly 60% of all
mortalities. One of the diagnostic tests currently in use as a
universal method for measuring hemostatic disorders is the
thrombin generation test TGT developed by Giesen and
co-workers.3–5 This hemostatic disorders diagnostic tool,
however, involves a highly complex, costly, and time-
consuming procedure that needs to be performed by a labo-
ratory specialist. In contrast to conventional diagnostics,
novel technology enabled by developments in microfluidics
allows rapid diagnosis of blood or plasma samples at the
patient’s bed, the so-called point-of-care tests.6,7 Ideally, such
tests can even be carried out by a patient himself enabling
rapid diagnosis, which then facilitates the patient to adjust
his medical treatment and monitor the development of his
disease.
Since the introduction of microfluidic systems by Manz
et al.,8 miniaturization of many chemical and biological pro-
cesses has experienced a rapid growth.9 As evidenced by the
number of commercial applications described, application of
microfluidic systems in a clinical environment has increased
drastically.10 Several restrictions such as the detection limit
of the analytes, signal to noise ratio in the system, and/or
photobleaching of the fluorescent samples,11 however, still
limit the number of diagnostic applications. Nevertheless, in
the field of microfluidics a great interest exists for cardiac
diagnostics. Schembri et al.12 were the first to describe a
whole blood multiple analyte analyzer using centrifugation
and capillary forces. This centrifugal process for the extrac-
tion of plasma from sediment was later also used by Hae-
berle et al.13 Other separation techniques applied were based
on the bifurcation law14 or interchannel microstructures.15
Work by Song et al.16 demonstrated that clotting times of
whole blood and plasma could be determined in very small
volumes using a plug-based microfluidic system. Elaborating
on the results of Hemker et al.,5 we envisioned that conven-
tional monitoring of thrombin generation could also be min-
iaturized resulting in a time-saving, accurate, easy-to-
operate, and cost-efficient test. More importantly, lab-on-a-
chip technology enables the use of a diversity of reagents for
simultaneous determination of different clotting factors inte-
grating multiple diagnostic tests onto one microchip. Auto-
mation of the whole sequence of handling will result in a
more robust and reliable system that is less error prone as
compared to the conventional test. In this contribution we
report the first example of a miniaturized thrombin genera-
tion test on a chip.
II. EXPERIMENTAL DETAILS
A. Equipment
Fluorescence microscopy was performed on a Zeiss Ax-
iovert 135 TV with a 10 /0.50 objective equipped with a
DAPI-Aniline blue filter, ex 385 nm. Images were recorded
by a Photometrics Coolsnap Camera with a shutter speed of
12 s. As a 96-wells plate fluorometer a Multicounter Wallac
Victor2 equipped with an Umbelliferone filter, ex 385 nm,
T=25 °C was used. The setup that was used to perform the
TGT in a microreactor is schematically depicted in Fig. 1a.
A commercially available microreactor type TD18, internal
volume 3.8 l was purchased from Micronit Microfluidics
BV Enschede, The Netherlands. All syringes Harvard ap-
paratus; high pressure syringe, 2.5 ml mounted on a syringe
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pump New Era; type NE-1000 were connected using
Swagelok connections to FEP tubing Upchurch Scientific;
type: 1529L 1 /16 OD, 1 /100 ID. At the end of each tub-
ing, a special flat “bottom headless nut” Upchurch Scien-
tific; type: M-660 was introduced, which pressed down onto
a special flat bottom ferrule Upchurch Scientific; type:
M-650 to achieve a gas tight fluid connection to the mi-
croreactor. The microreactor was positioned in a chipholder
custom built17 with threaded holes on the top side in which
the nuts were screwed. The chipholder was positioned onto
the fluorescence microscope during the measurements.
B. Materials
Fluorogenic substrate Cbz-Gly-Gly-Arg-AMC I-1140
was obtained from Bachem A.G. Bubendorf, Switzerland.
A solution referred to as Fluo contained 7.5 l of a 100 mM
solution of Cbz-Gly-Gly-Arg-AMC in dimethylsulfoxide
DMSO and 292.5 l buffer Hepes 20 mM, pH 7.35, con-
taining 60 g/l BSA bovine serum albumin, Sigma, A-7030,
referred to as BSA60. A solution referred to as FluCa con-
tained 25 l of a 100 mM solution of Cbz-Gly-Gly-Arg-
AMC in DMSO, 875 l buffer BSA60 and 100 l 1M
CaCl2, resulting in a concentration of 2.5 mM in fluorogenic
substrate and 100 mM in CaCl2. Platelet poor plasma PPP
was prepared according to literature5 and stored at −80 °C.
Prior to use the sample was allowed to warm to room tem-
perature. A solution referred to as TF/PL consisted of 30 pM
relipidated Tissue Factor Innovin®, Dade Behring, Mar-
burg, Germany and 24 M phospholipids in Hepes-
buffered saline, prepared according to literature.18 All other
reagents were used as purchased.
Hydrophilic fused silica capillaries with a polyimide
coating were obtained from PolyMicro Eerbeek, The Neth-
erlands with an inner diameter of 100 m, outer diameter
of 365 m, and a length of 30 cm total internal volume
2.4 l.
C. Methods
A transparent detection window in the capillaries typi-
cally 2–3 cm in length was created by removing the coating
by applying a short typically 1–2 s external heat source
typically a flame. The soot formed was easily removed
from the capillary by a wet tissue leaving the detection win-
dow.
To construct a hydrophobic capillary, a solution of 10 l
ODS-Cl octadecyltrichlorosilane dissolved in 1 ml of tolu-
ene was pumped through the capillary. The solution in the
capillary was left for 15–20 min. Subsequently, approxi-
mately 2 ml of toluene 1 ml min−1 was pumped through.
Finally, approximately 2 ml of acetone was pumped through
1 ml min−1 and the capillary was dried with pressurized
dry air.
Conventional TGT in a 96-wells plate was carried out
using the following procedure. The sample PPP was al-
lowed to warm to room temperature prior to use. 80 l
Sample PPP, 20 l TF/PL solution and 20 l FluCa were
added to four wells in a 96-wells titer plate and mixed for 10
s t=0. The titer plate was placed in the 96-wells plate fluo-
rometer. The temperature was set to 25 °C and the fluores-
cence measurement was started measuring every 15 s for 40
min.
TGT in capillaries was performed using 40 l of sample
PPP, which was premixed with 10 l FluCa in order to
initiate the test t=0. Subsequently, the mixed solution was
brought into the capillary by applying reduced pressure and
the fluorescence was measured by fluorescence microscopy.
Mixing experiments in the micromixer were performed
by filling syringe I with Rhodamine B solution 1 mg/ml in
de-ionized water and syringe II with de-ionized water. Both
syringes were mounted on the syringe pumps and connected
to the microchip. Pump I was programmed to deliver 50 l
at a pump rate of 450 l min−1. Pump II was programmed to
deliver 25 l at a pump rate of 225 l min−1. The micro-
chip was positioned on the microscope Zeiss, Axiovert 40
MAT and the mixing experiment was initiated by starting
both pumps at exactly the same time. Images were recorded
with a digital camera Carl Zeiss, Axiocam MRc5.
TGT in a micromixer was carried out by filling syringe I
with sample PPP, typically 300 l and syringe II with re-
FIG. 1. Color online a Schematic representation of conventional TG
testing. b Schematic representation of the setup for TG-Testing in capillar-
ies. c Schematic representation of the microreactor setup used for the TGT
experiments.
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agent typically 150 l TF/PL solution and 150 l
FluCa.19 Both syringes were mounted on the syringe pumps
and connected to the microreactor. Pump I was programmed
to deliver 50 l at a pump rate of 450 l min−1. Pump II
was programmed to deliver 25 l at a pump rate of
225 l min−1. To initiate the reaction, both pumps were
started exactly at the same time, and the fluorescence in the
microreactor was measured for 40 min by fluorescence mi-
croscopy.
III. RESULTS AND DISCUSSION
For reliable miniaturization of the conventional thrombin
generation test several parameters such as temperature, de-
tection limit, protein-surface interactions, and mixing behav-
ior required profound investigation. Temperature plays an
important role in many biological processes including throm-
bin generation. Preferably enzymatic reactions are carried
out at 37 °C. However, our microfluidic device was de-
signed to function at ambient temperature. As a point of ref-
erence the conventional thrombin generation test therefore
first needed to be performed in a 96-wells plate Fig. 1a at
25 °C instead of the usual 37 °C.
Miniaturization of the 96-wells plate to capillaries Fig.
1b will result in sample volume reduction and efficient and
reliable detection becomes an issue to address. In the con-
ventional test the fluorophore 7-amino-4-methyl-coumarin,
AMC is liberated and measured using a standard 96-wells
plate fluorometer. In the miniaturized setup Fig. 1b fluo-
rescence microscopy was used in order to detect the fluores-
cent signal, and the efficiency of this method had to be de-
termined. The use of microchannels for the TGT results in a
diagnostic device with an increased surface to volume ratio
when compared to the conventional test. The effect of the
hydrophilicity of the channel walls therefore also had to be
taken into consideration as protein-surface interactions affect
coagulation behavior. Finally, in order to obtain an efficient
mixing procedure of the sample and diagnostic fluid, we in-
vestigated the use of a micromixer Fig. 1c.
Performing the thrombin generation test in a 96-wells
plate at 25 °C resulted in a fluorescence trace as a function
of time as depicted in Fig. 2a. The thrombin activity rapidly
decreases in plasma as a result of plasma inhibitors. The
most important of these inhibitors, 2-macroglobulin, encap-
sulates thrombin, forming a 2-M-T complex. This 2-M-T
complex switches off all biological activity of thrombin i.e.,
coagulation initiation except for the amidolytic action on
small substrates.20 Consequently, there is continuous hy-
drolysis of fluorescent substrate Cbz-Gly-Gly-Arg-AMC
due to the presence of the 2-M-T complex, giving rise to an
increased fluorescence signal. Thus the thrombin generation
curve or thrombogram is comprised of the fluorescent sig-
nal produced by free thrombin and the complex of thrombin
with 2-macroglobulin. Mathematical processing21 was ap-
plied to convert the fluorescent signal into free thrombin ac-
tivity by subtracting the 2M-T activity, generating Fig.
2b.22 The results shown in Fig. 2 demonstrate that perform-
ing the TGT at a lower temperature provided comparable
thrombograms, although the time-to-peak was significantly
prolonged. It could however be concluded that no intrinsic
problems were encountered by performing the test at ambi-
ent temperature.
The conventional TGT consumes 80 l of sample and
40 l of reagents per test, which can easily be reduced upon
usage of capillaries or other microfluidic systems. In the first
miniaturized experiments, the sample and reagents were pre-
mixed outside a microchannel, after which the mixture was
introduced into a capillary by reduced pressure and the
thrombin generation was measured schematically depicted
in Fig. 1b. Initially, we tested the TGT in fused silica
capillaries with an inner diameter of 100 m total internal
volume 2.4 l. To investigate the effect of the polarity of
the surface, both hydrophobic and hydrophilic capillaries
were examined at 25 °C Fig. 3.
The hydrophobicity has a significant effect on the time to
peak, as shown in Fig. 3. Using a hydrophobic channel re-
sulted in a delay of the time to peak of approximately 13 min
in comparison with the hydrophilic channel 17.8 and 4.7
min., respectively. This could be explained by the enhanced
binding of proteins to the hydrophilic surface of the capillary
hence increasing the coagulation activity via the intrinsic
pathway i.e., coagulation in a blood vessel initiated by the
activation by certain negatively charged surfaces23. Compar-
ing the results of both capillaries with the established 96-
wells plate results, the hydrophobic capillary yielded the
more similar outcome, with no significant difference in the
time-to-peak parameter 17.8 and 15.8 min, respectively.
FIG. 2. Color online Conventional TGT at 25 °C using the setup as depicted in Fig. 1a a Measured fluorescence in sample PPP. b Thrombogram
obtained after mathematical processing.
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To demonstrate that thrombin generation could also be
measured in a microchip using a commercially available
micromixer, as depicted in Fig. 1c, we initially applied the
premixing method as described for the capillaries prior to
injection into the microchip. The fluorescence signal was
monitored during 40 min and after mathematical
processing,21 the thrombogram was generated Fig. 4.
The obtained thrombogram Fig. 4 demonstrates that
the thrombin generation can be monitored in the micromixer.
Remarkably, the time to peak 13.2 min was situated in
between the times found for the hydrophobic and hydrophilic
fused silica capillaries while the material of the microchip is
hydrophilic untreated borosilicate glass. The increased time
to peak might be explained by the slightly different compo-
sition of the channel material and the lower surface-to-
volume ratio of the microchip compared to the capillary
which could decrease the intrinsic coagulation activation.
Encouraged by these results, we investigated the possi-
bility to eliminate the premixing step by applying an excel-
lent micromixer chip.24,25 To evaluate the mixing behavior of
this micromixer, two aqueous solutions one containing the
fluorescent dye Rhodamine B, the other de-ionized water
were pumped at a controlled rate through the micromixer.
Figure 5 shows that after four mixing units mixing was com-
plete. By replacing the aqueous solution with a BSA buffer
solution closer related to physiological conditions, similar
mixing behavior was observed.21
Having established that the mixing in a micromixer oc-
curs rapidly, we proceeded by performing the TGT in this
specific micromixer. The premixing step was eliminated by
introducing the sample and reagent via separate syringes into
the microchip, as depicted in Fig. 1c. The pump rate for the
two solutions was set at a ratio of 2:1 sample:reagents.
After loading the microchip with the appropriate amount of
sample and reagent approximately 4 l thrombin genera-
tion was monitored during a period of 40 min. To our satis-
faction we obtained the thrombogram, as depicted in Fig. 6.
Comparing the on-chip mixing procedure with the pre-
mix method, modest variations in time to peak and peak
height were observed. The distribution is slightly broadened
indicating a delayed and prolonged thrombin generation.
This can possibly be explained by the low accessibility of
TF, which could be improved by changing the mixing ratio.26
Based on these results it can thus be concluded that the TGT
can be performed in a micromixer with efficient on-chip
mixing, lower sample volumes, and excellent detection.
FIG. 4. Color online Thrombogram recorded in the micromixer of sample
and reagents premixed prior to injection.
FIG. 3. Color online Thrombograms of both hydrophilic and hydrophobic
capillaries. For clarity reasons only the corrected TG curves are depicted.
FIG. 5. Color Combined images of five consecutive
mixing units of a mixing experiment in the microreac-
tor. Flow direction is from left to right. One of the aque-
ous phases is colored with a dye Rhodamine B to
visualize the mixing behavior in the micromixer.
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IV. CONCLUDING REMARKS
The focus of our research was to investigate the minia-
turization of the conventional thrombin generation test by
applying microfluidic devices. We demonstrated that throm-
bin generation can be measured in different microfluidic de-
vices with excellent detection. The use of microfluidics re-
sulted in 30-fold sample volume reduction. The influence of
protein-surface interaction was demonstrated using both hy-
drophilic and hydrophobic capillaries resulting in a large
shift in time to peak possibly as a result of contact activation
of the intrinsic coagulation pathway by the glass surface. The
use of a micromixer enabled us to perform efficient on-chip
mixing, which resulted in the successful measurement of a
thrombin generation curve. With this work we demonstrated
that microreactor technology is suitable for miniaturization
of the conventional thrombin generation test. As a next step
validation of this test by calibrating the fluorescent signal
and performing the TGT in a hydrophobic micromixer will
be examined.
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